Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Change in Accured Expenses (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Change in Accured Expenses for 13 consecutive years, with -$18.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 364.82% year-over-year to -$18.1 million, compared with a TTM value of -$10.9 million through Sep 2025, down 200.73%, and an annual FY2024 reading of $11.9 million, up 244.27% over the prior year.
  • Change in Accured Expenses was -$18.1 million for Q3 2025 at Aspen Aerogels, down from -$2.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $10.0 million in Q4 2024 and bottomed at -$18.1 million in Q3 2025.
  • Average Change in Accured Expenses over 5 years is -$268684.2, with a median of $481000.0 recorded in 2021.
  • Peak annual rise in Change in Accured Expenses hit 9706.06% in 2022, while the deepest fall reached 1851.14% in 2022.
  • Year by year, Change in Accured Expenses stood at $6.3 million in 2021, then plummeted by 48.1% to $3.3 million in 2022, then soared by 174.83% to $9.0 million in 2023, then increased by 11.02% to $10.0 million in 2024, then tumbled by 281.96% to -$18.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ASPN at -$18.1 million in Q3 2025, -$2.2 million in Q2 2025, and -$565000.0 in Q1 2025.